Edwards Lifesciences (EW) Long-Term Investments (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Long-Term Investments of $285.6 million for Q1 2026, up 2.77% year-over-year from $277.9 million in Q1 2025, and up 2.51% quarter-over-quarter from $278.6 million in Q4 2025.
Edwards Lifesciences (EW) Long-Term Investments (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Long-Term Investments history runs 18 years deep, the most recent figure standing at $285.6 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 2.77% year-over-year to $285.6 million; the TTM figure through Mar 2026 stood at $285.6 million (up 2.77% YoY), while the FY2025 annual figure was $278.6 million, down 9.52% from the prior year.
- Long-Term Investments for Q1 2026 stood at $285.6 million, up from $278.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $1.6 billion in Q1 2022, with the low at $274.7 million in Q3 2025.
- The 5-year median for Long-Term Investments is $455.6 million (2024), against an average of $694.0 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Investments soared 102.41% in 2022, then tumbled 58.74% in 2024.
- Edwards Lifesciences' Long-Term Investments stood at $1.2 billion in 2022, then tumbled by 52.87% to $583.9 million in 2023, then plunged by 47.27% to $307.9 million in 2024, then fell by 9.52% to $278.6 million in 2025, then advanced by 2.51% to $285.6 million in 2026.
- Business Quant data shows EW's Long-Term Investments at $285.6 million in Q1 2026, $278.6 million in Q4 2025, and $274.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 244.10 Mn |
| Mar 31, 2026 | 285.60 Mn |
| Dec 31, 2025 | 278.60 Mn |
| Sep 30, 2025 | 274.70 Mn |
| Jun 30, 2025 | 298.50 Mn |
| Mar 31, 2025 | 277.90 Mn |
| Dec 31, 2024 | 307.90 Mn |
| Sep 30, 2024 | 319.60 Mn |
| Jun 30, 2024 | 353.30 Mn |
| Mar 31, 2024 | 455.60 Mn |
| Dec 31, 2023 | 583.90 Mn |
| Sep 30, 2023 | 704.60 Mn |
| Jun 30, 2023 | 856.20 Mn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.38 Bn |
| Jun 30, 2022 | 1.49 Bn |
| Mar 31, 2022 | 1.62 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.28 Bn |